Causes of Non-invasive Fungal Sinusitis as Presented in Sohag University

Clinical Trial Description

In this study, the investigators will try to know the epidemiology of noninvasive fungal sinusitis, especially in recurrent cases This study will be carried out at sohag university hospital. Retrospective study Study period: 5 years (from August 2016 to August 2021. ) ;

Study Design

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06076304` - Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis - Pilot	Phase 4
Recruiting	`NCT03729258` - Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.	Phase 3
Recruiting	`NCT05454072` - Microbiota Transfer for Chronic Rhinosinusitis	N/A
Enrolling by invitation	`NCT05954273` - Maxillary Sinus Membrane Perforation Incidence During Osseodensification

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT06076304 - Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis - Pilot

Phase 4

Recruiting

NCT03729258 - Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.

Phase 3

Recruiting

NCT05454072 - Microbiota Transfer for Chronic Rhinosinusitis

N/A

Enrolling by invitation

NCT05954273 - Maxillary Sinus Membrane Perforation Incidence During Osseodensification

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05102539
Study type	Observational
Source	Sohag University
Contact
Status	Enrolling by invitation
Phase
Start date	October 2021
Completion date	August 2022

Causes of Non-invasive Fungal Sinusitis as Presented in Sohag University Hospital

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms